Hostname: page-component-76fb5796d-qxdb6 Total loading time: 0 Render date: 2024-04-26T18:07:40.501Z Has data issue: false hasContentIssue false

Treatment of catatonia with intravenous biperidene

Published online by Cambridge University Press:  02 January 2018

Michael Franz
Affiliation:
Centre for Psychiatry, The Independent Psychopathology Unit, Justus-Liebig-University School of Medicine, 35392 Giessen, Germany
Bernd Gallhofer
Affiliation:
Centre for Psychiatry, The Independent Psychopathology Unit, Justus-Liebig-University School of Medicine, 35392 Giessen, Germany
Walter T. Kanzow
Affiliation:
Centre for Psychiatry, The Independent Psychopathology Unit, Justus-Liebig-University School of Medicine, 35392 Giessen, Germany
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Columns
Copyright
Copyright © 1994 The Royal College of Psychiatrists 

References

American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders (3rd edn revised) (DSM–III–R). Washington DC: APA.Google Scholar
Hirschberg, E. (1964) Zur Frage psychischer Wirkungsqualitäten des Akinetons im Rahmen neuroleptischer Pharmakotherapie. Nervenarzt, 9, 419.Google Scholar
Larson, E. W., Pfennig, M. A. & Richelson, E. (1991) Selectivity of antimuscarinic compounds for muscarinic receptors of human brain and heart. Psychopharmacology, 103, 62165.Google Scholar
Salam, S. A. & Kilzieh, N. (1988) Lorazepam treatment of psychogenic catatonia: An update. Journal of Clinical Psychiatry, 49, 1621.Google Scholar
Stille, G. & Sayers, A. (1975) Die Immobilisationsreaktion der Ratte als tierexperimentelles Modell für die Katatonie. Pharmacopsychiatry, 8, 105114.Google Scholar
Winter, E. & Grosse, R. (1979) Zur Wirkung von Biperiden bei akuten substuporös-stuporösen Zuständen. Pharmacopsychiatry, 5, 383387.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.